Troy joined the Allen Institute for Immunology as the Director of Experimental Immunology in 2019 after 18 years at the University of Washington and Seattle Children’s Research Institute. He obtained an MD and PhD in Immunology from Vanderbilt University School of Medicine followed by a pediatrics residency and fellowship training in pediatric rheumatology and immunology at the University of Washington and Seattle Children’s.

Dr. Torgerson’s research is focused on understanding cellular and molecular drivers that mediate autoimmunity and immune dysregulation in humans. To do this, he has focused on defining and therapeutically modulating the immune defects in patients with genetic diseases that are predisposed to immune dysregulation and in patients with complex autoimmune diseases. He is the former president of the Clinical Immunology Society (CIS), a Human Immunology Project Consortium (HIPC) investigator, a member of the Primary Immune Deficiency Treatment Consortium (PIDTC) steering committee, and co-chair of the ClinGen Immunology Clinical Domain Working Group.